AndroGel Missed-Dose Protocol: What to Do When You Skip a Day of Testosterone Gel

AndroGel is a brand-name transdermal gel containing testosterone, an androgen hormone, available in 1% and 1.62% concentrations. It is FDA-approved for testosterone replacement in men with hypogonadism confirmed by clinical signs and laboratory testing. This article addresses missed once-daily applications; it does not apply to injectable testosterone esters, nasal testosterone, or subcutaneous pellets, which have different pharmacokinetics and different missed-dose implications.

The core, quotable point of this page: the FDA label for AndroGel instructs patients who miss a dose to apply it as soon as possible, or to skip it if it is almost time for the next scheduled dose, and never to double the applied amount. This instruction reflects the drug's skin-depot pharmacokinetics, in which one day's absorbed testosterone continues to buffer serum levels for several hours after the next dose would normally be due, so a single missed day is a manageable dip rather than an abrupt withdrawal. Repeated missed doses are a different clinical situation because they can push serum testosterone into a subtherapeutic range and complicate lab interpretation, and that pattern, not a single missed dose, is what warrants contacting your prescriber.

How AndroGel's delivery system explains the missed-dose instruction

AndroGel is a hydroalcoholic gel. After application, the alcohol carrier evaporates within minutes, leaving testosterone deposited in the outer layers of skin (the stratum corneum), which then acts as a reservoir. Testosterone absorbs from that reservoir into the bloodstream gradually over roughly 24 hours, which is why the product is dosed once daily rather than multiple times a day.

Because absorption from the prior day's application is still occurring when the next dose is due, a missed dose does not cause an abrupt drop to zero. Testosterone from the previous day's depot continues to support serum levels for some additional hours before declining below the treated range. This is the pharmacologic reason the FDA label allows same-day catch-up application but tells patients to skip the dose entirely, rather than double it, once it is close to the next scheduled time.

The 1.62% formulation uses a different gel vehicle with higher bioavailability per gram, so a smaller volume delivers a comparable dose. The missed-dose logic is the same for both strengths: the skin-depot mechanism, not the specific concentration, determines how forgiving a single missed day is.

Step-by-step: what to do when you miss a dose

The current FDA-approved prescribing information for AndroGel directs patients who miss a scheduled application to apply it as soon as they remember, and to skip the missed dose rather than double up if it is nearly time for the next one (per the current FDA-approved prescribing information for AndroGel 1.62%). Confirm this instruction against the label or insert that came with your specific prescription, since labeling language can be revised over time.

A practical way to apply that instruction:

• Same calendar day you remember: apply your normal single dose, then resume your usual time the next morning.
• Not until the next scheduled dose time: skip the missed dose. Apply only your normal single dose at the regular time. Do not apply extra gel to compensate.
• Two or more consecutive days missed: apply your normal single dose when you resume, and consider notifying your prescriber, particularly if you have lab work scheduled soon or you are also being monitored for hematocrit, PSA, or estradiol as part of your treatment.

Applying a double amount is not part of any labeled protocol for a missed dose and is discouraged for the reasons below.

A missed-dose conversation and monitoring framework

The FDA label gives a general instruction. It does not tell an individual patient how their specific hormone levels, symptoms, or lab schedule should be handled after a missed dose, and it cannot substitute for a conversation with the clinician managing your testosterone therapy. The table below separates what the label covers from what requires individualized judgment, and lists the points at which a missed dose stops being a routine event.

This table is a discussion aid, not a substitute for your prescriber's instructions. If your prescriber has given you a different individualized plan, follow that plan.

What is known and not known about testosterone levels after a missed dose

Established: Missing a single daily application of AndroGel produces a measurable decline in serum testosterone rather than an immediate crash, because absorption from the prior day's skin depot continues for some hours afterward. Resuming normal daily application restores levels toward the prior steady state within a short period, generally described in the literature as one to a few days rather than weeks. Repeated missed doses, in contrast, can bring serum testosterone into a subtherapeutic or frankly hypogonadal range and may cause symptoms such as fatigue or low mood.

Plausible but requiring verification for this page: Specific percentage drops, exact recovery-day counts, and specific adherence-rate figures that circulate in patient materials for testosterone gel are drawn from pharmacokinetic and adherence studies, but the precise figures should be checked against the primary literature before being treated as settled numbers for an individual patient. This page intentionally avoids presenting exact percentages as verified facts.

Not established at the individual level: How quickly any one man's levels fall after a missed dose, and how quickly they recover, depends on his baseline testosterone production, body composition, application site, and how consistently he applied the gel before the missed dose. A population-level average recovery time does not predict an individual's lab result on a given day.

Most men do not notice symptoms from a single missed dose, because testosterone's effects on energy, mood, and libido are mediated by gene transcription changes that unfold over days to weeks, not hours. A short dip in serum concentration does not reliably produce an immediate symptom flare. Two or more consecutive missed days is a different situation and can be symptomatic.

Why doubling the dose is discouraged

Applying two doses at once to "catch up" is not part of the labeled missed-dose instruction and carries two distinct risks.

First, doubling the applied gel volume can push peak serum testosterone above the normal physiologic range. Supratherapeutic testosterone is associated with an increased risk of erythrocytosis (elevated red blood cell mass), which is why testosterone therapy guidelines call for periodic hematocrit monitoring and dose reduction if hematocrit rises above a defined threshold. A single supratherapeutic spike from one doubled dose is unlikely by itself to cause polycythemia, but habitual dose-doubling establishes a pattern that increases that risk over time.

Second, doubling the dose increases the amount of unabsorbed testosterone left on the skin surface, which increases the window and surface area available for secondary transfer to another person through skin-to-skin contact. Regulatory safety communications have described cases of virilization in children who were unintentionally exposed to topical testosterone products through contact with a treated adult's skin. Applying more gel than prescribed, for any reason, works against the precautions meant to reduce that risk (covering the application site with clothing, washing hands after application, and avoiding skin contact with others until the gel has dried).

Factors that can affect how quickly you recover after a missed dose

Several variables plausibly affect how a missed dose plays out for a given person, based on general pharmacokinetic principles for transdermal testosterone, though exact magnitudes vary across studies and populations:

• Application site. The current label for the 1.62% formulation specifies the shoulders and upper arms based on absorption data supporting those sites; applying to a site not specified in your product's label may produce less consistent absorption.
• Body composition. Adipose tissue metabolizes testosterone to estradiol via aromatase. Men with higher body fat may run relatively lower free testosterone at a given dose, which could make a missed dose feel more noticeable, though this has not been quantified for this page and should be discussed with your prescriber if you notice a pattern.
• Showering timing. Showering soon after application, before the gel has fully dried and been absorbed, can reduce the amount of testosterone that reaches circulation. Waiting several hours after application before showering is a commonly recommended precaution, though the exact percentage reduction reported in specific studies requires verification before being cited as a fixed number.
• Competing topical products. Applying sunscreen or other topical products over or near the application site soon after dosing may interfere with absorption. Applying AndroGel to clean, dry skin free of other products, and waiting before applying anything else, is the more conservative approach.

Missed doses are common, and chronic partial adherence is the bigger clinical problem

Daily topical testosterone requires more day-to-day behavioral consistency than injectable formulations dosed every one to several weeks, and adherence research on daily topical hormone therapies generally finds that a substantial share of patients do not maintain consistent daily use over a year. Exact adherence percentages vary by study population and should not be treated as a fixed number without checking the specific source. The clinically relevant point is different from the percentage itself: men who apply gel on most but not all days of the week can settle into a gray zone where testosterone oscillates between low-normal and mildly hypogonadal, producing inconsistent symptom relief that is easy to misattribute to the medication "not working" rather than to inconsistent application.

If you find yourself regularly missing doses, that pattern, rather than any single missed day, is worth raising with your prescriber. Longer-acting injectable testosterone formulations, dosed every one to several weeks, remove the daily application requirement and may be a reasonable alternative for patients whose adherence to a daily gel is inconsistent, though the decision to switch formulations should weigh the individual's preferences, injection tolerance, and monitoring needs.

When a missed dose is a reason to contact your prescriber

A single missed dose is not an urgent situation. Contact your prescriber if any of the following apply:

• You have missed three or more consecutive days of applications.
• You have a lab draw for testosterone, hematocrit, PSA, or estradiol scheduled and your adherence has been inconsistent in the days beforehand, since a trough drawn during a missed-dose gap may not reflect your usual treated level.
• You develop a new rash, irritation, or reaction at the application site.
• You are considering stopping AndroGel intentionally. Testosterone therapy suppresses the body's own hormone-production axis, and abrupt discontinuation can cause symptomatic androgen deficiency in men whose natural production has been suppressed. Stopping should be done under medical guidance, not on your own.

Routine monitoring for men on testosterone therapy generally includes serum testosterone and hematocrit checks in the months after starting treatment and periodically thereafter; if your adherence has been inconsistent ahead of a scheduled check, tell your clinic so the result can be interpreted in that context.

Practical strategies to avoid missing doses

Pairing the application with an existing morning habit, such as brushing your teeth or making coffee, and keeping the gel pump or packet visible in your routine rather than stored out of sight, are commonly recommended low-effort adherence strategies. Phone reminders can help but tend to be a weaker substitute for a visible physical cue for a medication that requires a specific application routine.

For travel, keep the gel in its original packaging with the prescription label attached, since testosterone is a controlled substance in the United States, and pack a small buffer supply in case of travel delays.

If missed doses remain frequent despite these strategies, raise the option of switching to an injectable or other longer-acting testosterone formulation with your prescriber rather than continuing to manage frequent gaps in a daily topical regimen.